Treadwell Therapeutics website screenshot

Treadwell Therapeutics

Treadwell Therapeutics is a clinical-stage, multi-modality oncology company developing novel small-molecule therapeutics for highly aggressive cancers by targeting tumor-specific vulnerabilities such as aneuploidy and immunogenicity. Co-founded by Tak Wah Mak, PhD and Mark R. Bray, PhD, the company keeps drug discovery and clinical development under one roof and works out of Toronto (with a research footprint at the University Health Network), New York and Hong Kong. Its internally developed pipeline includes CFI-400945, an oral PLK4 inhibitor in Phase 1/2 studies across triple-negative breast cancer, prostate cancer and acute myeloid leukemia (FDA Fast Track designation); CFI-402257, a TTK inhibitor in Phase 1b/2; and CFI-402411, a first-in-class HPK1 inhibitor. Treadwell is a therapeutics developer, not a software vendor - it publishes no developer program, no public API, and no machine-readable API contract. Profiled by API Evangelist from its own public corporate site.

Treadwell Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Life Sciences.

Treadwell Therapeutics’ developer surface includes engineering blog and 7 more developer resources.

6.7/100 minimal ▬ flat Agent 3/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyLife SciencesHealthcareClinical TrialsDrug Discovery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/treadwell-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Pricing Plans 1

Published pricing tiers and plan structures.

Rate Limits 1

Documented rate limits and quota policies.

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Treadwell Therapeutics Domain Security

TLSv1.3 · DNSSEC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: treadwell-therapeutics
name: Treadwell Therapeutics
description: Treadwell Therapeutics is a clinical-stage, multi-modality oncology company developing novel small-molecule therapeutics
  for highly aggressive cancers by targeting tumor-specific vulnerabilities such as aneuploidy and immunogenicity. Co-founded
  by Tak Wah Mak, PhD and Mark R. Bray, PhD, the company keeps drug discovery and clinical development under one roof and
  works out of Toronto (with a research footprint at the University Health Network), New York and Hong Kong. Its internally
  developed pipeline includes CFI-400945, an oral PLK4 inhibitor in Phase 1/2 studies across triple-negative breast cancer,
  prostate cancer and acute myeloid leukemia (FDA Fast Track designation); CFI-402257, a TTK inhibitor in Phase 1b/2; and
  CFI-402411, a first-in-class HPK1 inhibitor. Treadwell is a therapeutics developer, not a software vendor - it publishes
  no developer program, no public API, and no machine-readable API contract. Profiled by API Evangelist from its own public
  corporate site.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://treadwelltx.com/wp-content/uploads/logo.png
url: https://raw.githubusercontent.com/api-evangelist/treadwell-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-30'
modified: '2026-08-30'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Life Sciences
- Healthcare
- Clinical Trials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/treadwell-therapeutics-domain-security.yml
- type: Website
  url: https://treadwelltx.com/
- type: Blog
  url: https://treadwelltx.com/news/
- type: BlogRSS
  url: https://treadwelltx.com/feed/
- type: TermsOfService
  url: https://treadwelltx.com/terms-of-use/
- type: LLMsTxt
  url: llms/treadwell-therapeutics-llms.txt
- type: Plans
  url: plans/treadwell-therapeutics-plans-pricing.yml
- type: RateLimits
  url: rate-limits/treadwell-therapeutics-rate-limits.yml
x-enrichment:
  date: '2026-08-30'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Treadwell Therapeutics is a privately held clinical-stage oncology drug developer whose entire web presence is an
    eight-page WordPress marketing site on Flywheel - the only machine-readable things it serves are an SEO-plugin llms.txt
    and the WordPress core wp-json CMS index, and every OpenAPI/Swagger/GraphQL/.well-known path returns the site's WordPress
    404 template.
  evidence:
  - url: https://treadwelltx.com/openapi.json
    status: 404
  - url: https://treadwelltx.com/graphql
    status: 404
  - url: https://treadwelltx.com/.well-known/api-catalog
    status: 404
  - url: https://treadwelltx.com/.well-known/agent-card.json
    status: 404
  - url: https://treadwelltx.com/llms.txt
    status: 200
  - url: https://treadwelltx.com/wp-json/
    status: 200
  checked: '2026-08-30'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/treadwell-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/treadwell-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/treadwell-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.